Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |